Literature DB >> 9295267

Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.

D E Sleat1, R J Donnelly, H Lackland, C G Liu, I Sohar, R K Pullarkat, P Lobel.   

Abstract

Classical late-infantile neuronal ceroid lipofuscinosis (LINCL) is a fatal neurodegenerative disease whose defective gene has remained elusive. A molecular basis for LINCL was determined with an approach applicable to other lysosomal storage diseases. When the mannose 6-phosphate modification of newly synthesized lysosomal enzymes was used as an affinity marker, a single protein was identified that is absent in LINCL. Sequence comparisons suggest that this protein is a pepstatin-insensitive lysosomal peptidase, and a corresponding enzymatic activity was deficient in LINCL autopsy specimens. Mutations in the gene encoding this protein were identified in LINCL patients but not in normal controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295267     DOI: 10.1126/science.277.5333.1802

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  130 in total

Review 1.  Genetics of childhood epilepsy.

Authors:  R Robinson; M Gardiner
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  Proteomic approach for the elucidation of biological defects in autism.

Authors:  M A Junaid; R K Pullarkat
Journal:  J Autism Dev Disord       Date:  2001-12

3.  A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Authors:  Lakshya Bajaj; Jaiprakash Sharma; Alberto di Ronza; Pengcheng Zhang; Aiden Eblimit; Rituraj Pal; Dany Roman; John R Collette; Clarissa Booth; Kevin T Chang; Richard N Sifers; Sung Y Jung; Jill M Weimer; Rui Chen; Randy W Schekman; Marco Sardiello
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

4.  Juvenile neuronal ceroid lipofuscinosis.

Authors:  S Gulati; R Maheshwari; M Kabra; I C Verma; V Kalra
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

5.  Collagenolytic serine-carboxyl proteinase from Alicyclobacillus sendaiensis strain NTAP-1: purification, characterization, gene cloning, and heterologous expression.

Authors:  Naoki Tsuruoka; Toru Nakayama; Masako Ashida; Hisashi Hemmi; Masahiro Nakao; Hiroyuki Minakata; Hiroshi Oyama; Kohei Oda; Tokuzo Nishino
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

6.  Aorsin, a novel serine proteinase with trypsin-like specificity at acidic pH.

Authors:  Byung Rho Lee; Masato Furukawa; Koichiro Yamashita; Yurie Kanasugi; Choko Kawabata; Kenichi Hirano; Kenichi Ando; Eiji Ichishima
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses.

Authors:  D E Sleat; I Sohar; P S Pullarkat; P Lobel; R K Pullarkat
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy.

Authors:  Wensi Song; Fan Wang; Parisa Lotfi; Marco Sardiello; Laura Segatori
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

10.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.